Reviva Pharmaceuticals: Advancing CNS, Cardiovascular & Metabolic Treatments Amid Volatile Stock Performance
Reviva Pharmaceuticals, a Nasdaq‑listed biopharma, is advancing innovative CNS, cardiovascular, metabolic, and inflammatory therapies amid volatile stock swings and strong R&D focus.
- Reviva Pharmaceuticals Holdings Inc
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- AI generated
2 minutes to read



